Neuroimmunology
Autoimmune glial fibrillary acidic protein (GFAP) astrocytopathy
Aug. 15, 2024
MedLink®, LLC
3525 Del Mar Heights Rd, Ste 304
San Diego, CA 92130-2122
Toll Free (U.S. + Canada): 800-452-2400
US Number: +1-619-640-4660
Support: service@medlink.com
Editor: editor@medlink.com
ISSN: 2831-9125
Toll Free (U.S. + Canada): 800-452-2400
US Number: +1-619-640-4660
Support: service@medlink.com
Editor: editor@medlink.com
ISSN: 2831-9125
Nearly 3,000 illustrations, including video clips of neurologic disorders.
Every article is reviewed by our esteemed Editorial Board for accuracy and currency.
Full spectrum of neurology in 1,200 comprehensive articles.
Listen to MedLink on the go with Audio versions of each article.
Behring introduced serum therapy for diphtheria and was controversially awarded a solo Nobel Prize in Physiology or Medicine for this in 1901. Actually, the work had been done by both Behring and Paul Ehrlich (1854-1915), but Behring apparently cheated Ehrlich out of both recognition and financial reward. They had produced their diphtheria serum by repeatedly injecting the bacterial toxin into a horse. The serum was then used effectively during an epidemic in Germany. A chemical company offered a contract to both men, but Behring took the considerable financial rewards for himself. (Courtesy of the University of Marburg, Germany.)